Guardant Health (GH) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
4 figures withheld by our checks. Each blank figure names its reason.
101.3mn → 125.4mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
+37.7% YoY in FY25 · 4.9% of revenue.
$62.7M returned vs $−233.1M of FCF in FY25. Free cash flow was negative, so returns were funded from the balance sheet rather than from cash generation.
-42¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Net margin -42.4% is below the sector median.
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 1,278,884.0 | 982,021.0 | 739,016.0 | 563,948.0 | 449,538.0 | 373,653.0 | ▲32.9% | +27.3% |
Cost of revenue | 445,182.0 | 349,007.0 | 289,799.0 | 227,052.0 | 8,126.0 | 12,516.0 | ▲20.4% | +129.8% |
Gross profit | 833,702.0 | 633,014.0 | 449,217.0 | 336,896.0 | —A | —A | ▲40.9% | +37.1% |
Research & development | 386,673.0 | 364,191.0 | 347,753.0 | 367,194.0 | 373,807.0 | 263,221.0 | ▲4.7% | +8.5% |
Selling, general & admin | 271,381.0 | 211,410.0 | 180,123.0 | 239,200.0 | 163,956.0 | 206,640.0 | ▲17.4% | +0.6% |
Total operating expenses | 1,337,740.0 | 1,070,262.0 | 892,811.0 | 901,621.0 | 985,790.0 | 772,138.0 | ▲19.9% | +8.5% |
Operating incomefeeds ROC rank | −504,038.0 | −437,248.0 | −443,594.0 | −564,725.0 | −544,378.0 | −411,001.0 | ▲1.4% | — |
Other income, net | 18,138.0 | 19,708.0 | 8,505.0 | 85,961.0 | −109,071.0 | 26,531.0 | — | — |
Pretax income | −485,900.0 | −417,540.0 | −435,089.0 | −478,764.0 | −653,449.0 | −384,470.0 | ▲4.0% | — |
Income tax | −827.0 | −1,263.0 | 1,284.0 | 685.0 | 1,139.0 | 300.0 | — | — |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −485,073.0 | −416,277.0 | −436,373.0 | −479,449.0 | −654,588.0 | −384,770.0 | ▲4.6% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −3.69 | −3.32 | −3.56 | −4.28 | −6.41 | −4.00 | ▲6.7% | — |
Diluted shares (mn) | 134.42 | 125.37 | 122.75 | 111.99 | 102.18 | 101.31 | ▲2.1% | +5.5% |
| Margins | ||||||||
Gross margin49th pct in Healthcare | 65.2% | 64.5% | 60.8% | 59.7% | —A | —A | ▲3.7pp | +4.7pp |
Operating margin | −39.4% | −44.5% | −60.0% | −100.1% | −121.1% | −110.0% | ▲15.5pp | +65.5pp |
Net margin16th pct in Healthcare | −37.9% | −42.4% | −59.0% | −85.0% | −145.6% | −103.0% | ▲16.7pp | +60.6pp |
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Guardant Health's revenue last fiscal year?
Guardant Health reported revenue of $982.0M in fiscal 2025, up 32.9% from fiscal 2024.
What was Guardant Health's net income?
Guardant Health reported net income of −$416.3M in fiscal 2025, a net margin of −42.4%.

